FI950866A0 - Insertion of macromolecules into the cell nucleus by means of a translocation signal - Google Patents

Insertion of macromolecules into the cell nucleus by means of a translocation signal

Info

Publication number
FI950866A0
FI950866A0 FI950866A FI950866A FI950866A0 FI 950866 A0 FI950866 A0 FI 950866A0 FI 950866 A FI950866 A FI 950866A FI 950866 A FI950866 A FI 950866A FI 950866 A0 FI950866 A0 FI 950866A0
Authority
FI
Finland
Prior art keywords
macromolecules
cell nucleus
translocation signal
translocation
signal
Prior art date
Application number
FI950866A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI950866A (en
Inventor
Thomas R Barnett
Rathindra C Das
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Publication of FI950866A0 publication Critical patent/FI950866A0/en
Publication of FI950866A publication Critical patent/FI950866A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Formation Of Insulating Films (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI950866A 1992-08-25 1995-02-24 Export of macromolecules to the cell nucleus with the aid of a translocation signal FI950866A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93507492A 1992-08-25 1992-08-25
PCT/US1993/007945 WO1994004696A1 (en) 1992-08-25 1993-08-24 Translocation signal facilitated nuclear delivery of macromolecules

Publications (2)

Publication Number Publication Date
FI950866A0 true FI950866A0 (en) 1995-02-24
FI950866A FI950866A (en) 1995-04-24

Family

ID=25466554

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950866A FI950866A (en) 1992-08-25 1995-02-24 Export of macromolecules to the cell nucleus with the aid of a translocation signal

Country Status (10)

Country Link
EP (1) EP0658210A1 (en)
JP (1) JPH08504565A (en)
KR (1) KR950703650A (en)
AU (1) AU674026B2 (en)
CA (1) CA2143308A1 (en)
FI (1) FI950866A (en)
IL (1) IL106760A (en)
NZ (1) NZ255870A (en)
WO (1) WO1994004696A1 (en)
ZA (1) ZA936189B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674977A (en) * 1993-02-05 1997-10-07 The Ontario Cancer Institute Branched synthetic peptide conjugate
EP0693939A1 (en) * 1993-04-14 1996-01-31 Roche Diagnostics GmbH Nucleic acid tranfer peptides and their use for injecting nucleic acids into eucaryotic cells
EP0745134A1 (en) 1994-02-22 1996-12-04 Danafarber Cancer Institute Nucleic acid delivery system, method of synthesis and uses thereof
US6037329A (en) 1994-03-15 2000-03-14 Selective Genetics, Inc. Compositions containing nucleic acids and ligands for therapeutic treatment
CA2187818A1 (en) * 1994-04-15 1995-10-26 Robert W. Overell Gene delivery fusion proteins
US6468981B1 (en) * 1994-07-29 2002-10-22 Emory University Compositions and methods for targeting pharmaceutically active materials to cells containing androgen receptors
DE69521331T2 (en) * 1994-11-01 2001-09-20 Winfried Wels NUCLEIC ACID ENTRY SYSTEM
US6051429A (en) * 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
EP0892811B1 (en) * 1996-03-26 2002-12-18 Razvan T. Radulescu Peptides with antiproliferative properties
US5877282A (en) * 1996-09-20 1999-03-02 Bristol-Myers Squibb Company Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
US5962415A (en) * 1996-09-20 1999-10-05 Bristol-Myers Squibb Co. Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof
DE19649645A1 (en) * 1996-11-29 1998-06-04 Hoechst Ag Multiple functional ligand system for target cell-specific transfer of nucleotide sequences
WO1998042876A1 (en) * 1997-03-26 1998-10-01 Board Of Regents, The University Of Texas System Methods and compositions for using membrane-penetrating proteins to carry materials across cell membranes
GB9713122D0 (en) * 1997-06-20 1997-08-27 Chiron Spa Novel method of DNA transfer into cells
WO1999007723A1 (en) * 1997-08-07 1999-02-18 University Of Maryland, Baltimore Nucleic acid uptake and release vehicle
EP2298728A1 (en) 1998-11-12 2011-03-23 Life Technologies Corporation Transfection reagents
WO2000045850A2 (en) * 1999-02-06 2000-08-10 Aurx Inc. Drug delivery vehicle
DE19910419A1 (en) * 1999-03-10 2000-09-21 Aventis Pharma Gmbh Target Cell-Specific Multivalent Proteins (MVP)
FR2793414B1 (en) * 1999-05-10 2003-05-23 Centre Nat Rech Scient NUCLEIC ACID-ANTIBODY CONJUGATE FOR DELIVERING FOREIGN NUCLEIC ACID TO CELLS
US6387684B1 (en) * 1999-09-13 2002-05-14 Academia Sinica Topoisomerase 1-mediated DNA delivery
EP1222289B1 (en) * 1999-10-20 2008-04-16 The Johns Hopkins University School Of Medicine Chimeric immunogenic compositions and nucleic acids encoding them
US8128922B2 (en) 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
DE10019157A1 (en) * 2000-04-18 2001-11-15 Stefan Duebel Method for introducing ligands into living cells
CA2417214C (en) 2000-08-03 2016-06-21 Johns Hopkins University Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
WO2002083166A1 (en) * 2001-04-10 2002-10-24 Santen Pharmaceutical Co., Ltd. Interferon-polymer complexes and medicinal use thereof
EP1947116B1 (en) * 2003-02-10 2017-06-21 2-BBB Medicines B.V. Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions
WO2004098526A2 (en) 2003-05-05 2004-11-18 Johns Hopkins University Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
ATE469984T1 (en) 2003-12-01 2010-06-15 Life Technologies Corp NUCLEIC ACID MOLECULES CONTAINING RECOMBINATION SITE AND METHOD FOR USE THEREOF
WO2006073970A2 (en) 2005-01-06 2006-07-13 The Johns Hopkins University Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
US9085638B2 (en) 2007-03-07 2015-07-21 The Johns Hopkins University DNA vaccine enhancement with MHC class II activators
CN102105488A (en) * 2008-07-18 2011-06-22 朱志强 Methods of long-term culture of eukaryotic cells and uses thereof
US10195280B2 (en) 2014-07-15 2019-02-05 Life Technologies Corporation Compositions and methods for efficient delivery of molecules to cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0506884T3 (en) * 1989-12-21 1996-11-04 Whitehead Biomedical Inst Method of delivering molecules to eukaryotic cells
WO1992005250A1 (en) * 1990-09-25 1992-04-02 University Of Connecticut Prolonging expression of polynucleotides introduced into a cell
DE4139001A1 (en) * 1991-11-27 1993-06-03 Boehringer Mannheim Gmbh PROCESS FOR INJECTION OF NUCLEAR ACIDS IN CELLS
WO1993017102A1 (en) * 1992-02-19 1993-09-02 The Trustees Of The University Of Pennsylvania MODULATIONS OF CELLULAR FUNCTIONS WITH HnRNP PROTEINS
EP0632722A4 (en) * 1992-03-20 1997-07-30 Baylor College Medicine A dna transporter system and method of use.

Also Published As

Publication number Publication date
KR950703650A (en) 1995-09-20
FI950866A (en) 1995-04-24
AU5088593A (en) 1994-03-15
AU674026B2 (en) 1996-12-05
NZ255870A (en) 1996-09-25
CA2143308A1 (en) 1994-03-03
JPH08504565A (en) 1996-05-21
EP0658210A1 (en) 1995-06-21
ZA936189B (en) 1995-01-10
WO1994004696A1 (en) 1994-03-03
IL106760A (en) 1999-12-31
IL106760A0 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
FI950866A0 (en) Insertion of macromolecules into the cell nucleus by means of a translocation signal
BR8207237A (en) "SIGNAL SYNCHRONIZATION SYSTEM"
FI932823A0 (en) Anordning och foerfarande Foer corrigation av en foervraengd signal i en mottagare
GB8824979D0 (en) Optical wide-angle sensors
FI924455A0 (en) FOERFARANDE FOER MAETNING AV LEDERS OCH TILL DESSA ANSLUTNA MUSKLERS FUNKTION
FI896158A (en) FOERFARANDE OCH ARRANGEMANG FOER EFFEKTIVERING AV TILLVARATAGANDE AV AVGASERNAS VAERMEENERGI VID STORA DIESELMOTORER.
HK797A (en) Signal phase alignment circuitry
FI884096A0 (en) FOERFARANDE OCH ANORDNING FOER SEPARATION AV STORA MAKROMOLEKYLER MED ELEKTROFORESEN.
GB8830417D0 (en) Substituted styrene derivatives
FI890997A0 (en) SYSTEM FOER OEVERVAKNING OCH BESTAEMNING AV BATTERIES LADDNINGSNIVAO SAERSKILT VID MATNINGSENHETEN FOER RESERVSTROEM.
MX165616B (en) CLOSING SYSTEM OF A TOP CABINET IN A CABINET
EP0421752A3 (en) Substituted acrylamido-penicillanic acid derivatives
EP0468352A3 (en) Novel nucleic acid derivatives
GB9101869D0 (en) Measurement coupling for low capacitances
NO932731D0 (en) NEW ISOBUTYL-SUBSTITUTED METANSULPHONYL-CHINOLYLMETOXY-PHENYL-CYCLOALKYLEDIC ACID AMAMIDS
AT389191B (en) METAL-ENCLOSED CONTROL CELL
GB8524963D0 (en) Web-feeding & serving methods
HU9400588D0 (en) 3-hydroxyanthranilic acid derivatives
NO950726D0 (en) Nuclear delivery of macromolecules with translocation signal
FR2616470B3 (en) STRUCTURAL DEVICE FOR WALL ELEMENTS
DE69232388T2 (en) Charge detection means
BR8800548A (en) NON-RESONANT SOUNDFLOWER SYSTEM
KR930023712U (en) Lane separator
KR930004794U (en) Automatic bag production system
KR940002229U (en) Synchronization signal discrimination circuit

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: BAYER CORPORATION

FD Application lapsed